Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 115

1.

Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation.

Desnos-Ollivier M, Patel S, Raoux-Barbot D, Heitman J, Dromer F; French Cryptococcosis Study Group..

MBio. 2015 Jun 9;6(3):e00311. doi: 10.1128/mBio.00311-15.

2.

Physicochemical and microbiological stability of azathioprine in InOrpha suspending agent studied under various conditions.

Amin A, Bourget P, Vidal F, Cartier F, Beauvais R, Afonso Vdo N.

Int J Pharm Compd. 2015 Jan-Feb;19(1):73-7.

PMID:
25902631
3.

Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey.

Rosenthal E, Roussillon C, Salmon-Céron D, Georget A, Hénard S, Huleux T, Gueit I, Mortier E, Costagliola D, Morlat P, Chêne G, Cacoub P; Mortalité 2010 and GERMIVIC study groups..

HIV Med. 2015 Apr;16(4):230-9. doi: 10.1111/hiv.12204.

PMID:
25522874
4.

The expression of the hepatocyte SLAMF3 (CD229) receptor enhances the hepatitis C virus infection.

Cartier F, Marcq I, Douam F, Ossart C, Regnier A, Debuysscher V, Lavillette D, Bouhlal H.

PLoS One. 2014 Jun 13;9(6):e99601. doi: 10.1371/journal.pone.0099601.

5.

Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progression.

Marcq I, Nyga R, Cartier F, Amrathlal RS, Ossart C, Ouled-Haddou H, Ghamlouch H, Galmiche A, Chatelain D, Lamotte L, Debuysscher V, Fuentes V, Nguyen-Khac E, Regimbeau JM, Marolleau JP, Latour S, Bouhlal H.

PLoS One. 2013 Dec 20;8(12):e82918. doi: 10.1371/journal.pone.0082918.

6.

Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: the EPIB 2008 study.

Piroth L, Pol S, Lacombe K, Miailhes P, Rami A, Rey D, Loustau-Ratti V, Morlat P, Goderel I, Sene D, Rosenthal E, Carrat F, Cacoub P; GERMIVIC Study Group..

J Hepatol. 2010 Dec;53(6):1006-12. doi: 10.1016/j.jhep.2010.04.041.

PMID:
20800920
7.

Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19).

Rosenthal E, Salmon-Céron D, Lewden C, Bouteloup V, Pialoux G, Bonnet F, Karmochkine M, May T, François M, Burty C, Jougla E, Costagliola D, Morlat P, Chêne G, Cacoub P; Mortavic/Mortalité 2005 Study Group..

HIV Med. 2009 May;10(5):282-9. doi: 10.1111/j.1468-1293.2008.00686.x.

8.

Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patients.

Michelet C, Ruffault A, Sébille V, Arvieux C, Jaccard P, Raffi F, Bazin C, Chapplain JM, Chauvin JP, Dohin E, Cartier F, Bellissant E.

Antimicrob Agents Chemother. 2001 Dec;45(12):3393-402.

9.

Evidence for the involvement of nitric oxide in the control of steroid secretion by the frog adrenal gland.

Cartier F, Do-Rego JL, Remy-Jouet I, Fournier A, Vaudry H, Delarue C.

J Steroid Biochem Mol Biol. 2001 Jun;77(4-5):251-9.

PMID:
11457663
10.

[Renal failure during treatment with Ambisome].

Arvieux C, Noyon V, Michelet C, Cartier F.

Presse Med. 2000 Oct 7;29(29):1600. French.

PMID:
11072358
11.
12.

Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine.

Michelet C, Bellissant E, Ruffault A, Arvieux C, Delfraissy JF, Raffi F, Bazin C, Renard I, Sébille V, Chauvin JP, Dohin E, Cartier F.

Clin Pharmacol Ther. 1999 Jun;65(6):661-71.

PMID:
10391672
13.

The stimulatory effect of endothelin-1 on frog adrenocortical cells is mediated through both the phospholipase C and the adenylyl cyclase transduction pathways.

Cartier F, Delarue C, Remy-Jouet I, Kodjo MK, Fournier A, Vaudry H.

Mol Cell Endocrinol. 1999 Jan 25;147(1-2):27-36.

PMID:
10195689
14.

Amplification of the six major human herpesviruses from cerebrospinal fluid by a single PCR.

Minjolle S, Michelet C, Jusselin I, Joannes M, Cartier F, Colimon R.

J Clin Microbiol. 1999 Apr;37(4):950-3.

15.

Opportunistic infections occurring during highly active antiretroviral treatment.

Michelet C, Arvieux C, François C, Besnier JM, Rogez JP, Breux JP, Souala F, Allavena C, Raffi F, Garre M, Cartier F.

AIDS. 1998 Oct 1;12(14):1815-22.

PMID:
9792382
16.

Mechanism of action of endothelins on adrenocortical cells.

Remy-Jouet I, Cartier F, Lesouhaitier O, Kuhn JM, Fournier A, Vaudry H, Delarue C.

Horm Metab Res. 1998 Jun-Jul;30(6-7):341-5. Review.

PMID:
9694560
17.

Mechanism of action of endothelin-1 in the frog adrenal gland.

Cartier F, Remy-Jouet I, Fournier A, Vaudry H, Delarue C.

Ann N Y Acad Sci. 1998 May 15;839:526-8. No abstract available.

PMID:
9629209
18.

The presence of cytoplasmic antineutrophil cytoplasmic antibodies (C-ANCA) in the course of subacute bacterial endocarditis with glomerular involvement, coincidence or association?

Subra JF, Michelet C, Laporte J, Carrere F, Reboul P, Cartier F, Saint-André JP, Chevailler A.

Clin Nephrol. 1998 Jan;49(1):15-8.

PMID:
9491280
19.

Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Fédération National des Centres de Lutte contre le SIDA.

Mouton Y, Alfandari S, Valette M, Cartier F, Dellamonica P, Humbert G, Lang JM, Massip P, Mechali D, Leclercq P, Modai J, Portier H.

AIDS. 1997 Oct;11(12):F101-5.

PMID:
9342061
20.

Longitudinal study of HIV-specific cytotoxic lymphocytes in HIV type 1-infected patients: relative balance between host immune response and the spread of HIV type 1 infection.

Bariou C, Genetet N, Ruffault A, Michelet C, Cartier F, Genetet B.

AIDS Res Hum Retroviruses. 1997 Oct 10;13(15):1301-12.

PMID:
9339847
Items per page

Supplemental Content

Loading ...
Support Center